PACTR202004808998657

Fractional carbon dioxide laser versus fractional Microneedle Radiofrequency in the Treatment of Post Burn Scars: a comparative randomized split scar study

Faculty of Medicine Cairo University Kasr AlAiny·Phase 1·Pan Africa Clinical Trials Registry·device·Device trialCompleted
Study focus
Intervention type
device
Sponsor & location
Primary sponsor
Faculty of Medicine Cairo University Kasr AlAiny
Funder
Funded by the investigators
Location
Egypt
Timeline & enrollment
Phase
Phase 1
Start date
Jan 01, 1900
End date
Jan 01, 1900
Summary

Fractional Co2 laser resurfacing produces columns of thermal damage at specific depths (Manstein and Herron, 2004). The thermal effect stimulates a therapeutic wound healing response with heat – shock proteins, myofibroblasts, and an increased collagen III production, and therapy raises a potential for texture remodeling so that the appearance of burn scar will be improved (Luabach and tannous, 2006). Fractional microneedle radiofrequency (FMR) devices deliver energy to the deep dermis through insulated microneedles without destroying the epidermis (Kim et al., 2014). Fractional thermal injury of deep dermal collagen induced a vigorous wound healing process leading to dermal remodeling and the generation of new collagen and elastin (Alexiades-Armenakas et al., 2008).TGFβ1 stimulates growth and collagen secretion and is thought to be intergral to keloid formation (Peltonenet et al., 1991). It induces an increase in fibronectin bio synthesis, a link glycoprotein that binds to integrins and other matrix molecules, forming an early component of granulation tissue more rapidly in keloid fibroblasts, suggesting modification of this regulatory pathway (Ashcroft et al., 1999). Our current study aims at assessing the efficacy of fractional CO2 laser compared to fractional microneedle radiofrequency in the treatment of post burn scars, and the implications of both treatment modalities on TGFβ1 level. By this study, we hope to pave the way for optimum treatment strategies for patients with this disfiguring condition.

ICD-10 classifications
Systemic disorders of connective tissue in diseases classified elsewhereSystemic disorders of connective tissue in other diseases classified elsewhereDiseases of the skin and subcutaneous tissueOther disorders of skin and subcutaneous tissue in diseases classified elsewhereOther disorders of the skin and subcutaneous tissue
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202004808998657
Type
Device Trial
About this record

Access comprehensive clinical trial information for PACTR202004808998657 through Pure Global AI's free database. This Phase 1 trial is sponsored by Faculty of Medicine Cairo University Kasr AlAiny and is currently Completed. The study focuses on Skin and Connective Tissue Diseases.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.